Table 3.
Patient characteristics by kidney recovery status within 12 mo of ESKD in patients with ESKD due to AKI
| Characteristics | Recovered, n=10,928 (34%) | Not Recovered, n=21,670 (66%) |
|---|---|---|
| Demographics | ||
| Age, yr | 62 (15) | 68 (13) |
| 18–30 | 3 | 1 |
| 30–40 | 6 | 2 |
| 40–50 | 11 | 6 |
| 50–60 | 21 | 15 |
| 60–70 | 25 | 25 |
| 70–80 | 23 | 29 |
| 80+ | 11 | 22 |
| Sex | ||
| Women | 38 | 44 |
| Race/ethnicity | ||
| Asian | 1 | 2 |
| Black | 13 | 16 |
| Hispanic | 7 | 7 |
| Native American | 0.5 | 0.5 |
| White | 78 | 75 |
| Body mass index (99% nonmissing), kg/m2 | 30 (8) | 29 (9) |
| <18.5 | 3 | 5 |
| 18.5–25 | 28 | 33 |
| 25–30 | 29 | 26 |
| >30 | 40 | 35 |
| Missing | 1 | 1 |
| Neighborhood poverty, % | ||
| <13.8 | 69 | 68 |
| 13.8 to <20 | 16 | 15 |
| 20 to <40 | 13 | 14 |
| ≥40 | 0.8 | 1 |
| Missing | 1 | 1 |
| Region | ||
| Midwest | 32 | 31 |
| Northeast | 18 | 24 |
| South | 35 | 29 |
| West | 16 | 16 |
| Unknown | <0.1 | <0.1 |
| Comorbidities | ||
| Congestive heart failure | 24 | 40 |
| Atherosclerotic heart disease + other | 36 | 46 |
| Hypertension | 68 | 75 |
| Diabetes mellitus | 36 | 42 |
| Cancer | 11 | 15 |
| Amputations | 21 | 3 |
| Peripheral vascular disease | 12 | 16 |
| Cerebrovascular accident/transient ischemic attack | 8 | 11 |
| Chronic obstructive pulmonary disease | 12 | 16 |
| Poor functional status | 19 | 30 |
| Laboratory values | ||
| Albumin (74% nonmissing), g/dl | 2.8 (0.8) | 2.8 (0.8) |
| <3.5 | 61 | 60 |
| ≥3.5 | 13 | 14 |
| Missing | 26 | 26 |
| Hemoglobin (90% nonmissing), g/dl | 10.2 (2.0) | 9.8 (1.7) |
| <11 | 63 | 71 |
| 11–12 | 13 | 11 |
| >12 | 14 | 7 |
| Missing | 11 | 10 |
| Care | ||
| History of nursing home | 12 | 19 |
| Nephrology care, mo | ||
| None | 73 | 56 |
| <12 | 12 | 22 |
| >12 | 4 | 9 |
| Unknown | 11 | 14 |
| Dialysis access/modality | ||
| Arteriovenous fistula/arteriovenous graft | 1.0 | 2 |
| Catheter | 99 | 96 |
| Peritoneal dialysis | 0.2 | 1.0 |
| Mortality | ||
| Time | ||
| 90 d | 2 | 23 |
| 12 mo | 11 | 49 |
| Anytime during follow-up | 40 | 80 |
| Transplant | ||
| Kidney transplant | 0.4 | 3 |
Data are represented as mean (SD) or proportion where appropriate.